Figure 7

Clinical correlation of WNT5B with metastasis and disease-free survival. (A) Differential expression of WNT5B in metastasis (M1) and non-metastasis (M0) groups using TCGA microarray data. P = 0.0221 (B) Disease-free survival analysis in the high WNT5B and low WNT5B groups using the combined data pulled out from the studies by Desmedt et al. and Wang et al. Probe, WNT5B_221029_s_at, n = 198, P = 0.0212. (C) Differential expression of MCL1 in metastasis (M1) and non-metastatsis (M0) groups using microarray data of Desmedt et al. (D) Disease-free survival analysis in the high MCL1 and low MCL1 groups using same microarray data collected from the study of Desmedt et al.